Remove Healthcare Remove Life Sciences Remove Medical Technology Remove Pharmaceuticals
article thumbnail

Vista Equity Partners Acquires Model N for $1.25B

HIT Consultant

What You Should Know: – Model N (NYSE: MODN), a leading provider of revenue optimization and compliance solutions for the life sciences and high-tech industries, has announced a definitive agreement to be acquired by Vista Equity Partners (“Vista”). per share in an all-cash transaction valued at approximately $1.25

article thumbnail

Quantifying the Long-Run Economic and Health Impact of Reduced Intellectual Property Protections for New Drugs

Healthcare ECONOMIST

Some policymakers have called for weakening of intellectual property protections for vaccines and other pharmaceutical products, with the aim to reduce the price and improve access to existing medical technologies, particularly in Eastern Europe and developing countries. The abstract is below.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Real-World Data Flow – The Only Way to Change Value-Based Care?

HIT Consultant

Healthcare interoperability issues have always been confusing, changing, and difficult to address. Instead, we have a system where each organization elects which technology tools to use and in what configuration. Manan Sheth, Sr. Technical Product Manager at CitiusTech. However, it is critical to the long-term success of a company.

article thumbnail

American Healthcare: The Challenge to Stay on Top

Healthcare Leadership Council

The Healthcare Leadership Council hosted a webinar which highlighted the relationship between intellectual property (IP) and innovation, a linkage that is critically important in healthcare. It was acknowledged that not all that long ago the United States not the world’s global leader in life sciences, as it is today.

article thumbnail

The Role of Intellectual Property in the Biopharmaceutical Sector

Healthcare ECONOMIST

 In the context of this fast-moving political debate, FTI Consulting supported INTERPAT, a non-profit biopharmaceutical consortium, and the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) in developing a White Paper and peer-reviewed article on the role of IP in the biopharmaceutical sector.

article thumbnail

Why #CES2022 Will Be Keynoted By A Health Care Innovator for the First Time

Health Populi

In October 2021, the Consumer Technology Association (CTA) announced that Robert Ford, CEO and President of Abbott, would give a keynote speech at CES 2022, the world’s largest annual convention of the technology industry.

article thumbnail

CPQ: Optimizing MedTech Operations and Sales to Accelerate Cash Flow

HIT Consultant

These inconsistencies and inaccuracies tend to compound in medical device and medical technology organizations where product portfolios are continually evolving, pricing fluctuates and quotes have to be configured to meet the specifications of each customer. But there are also some precautions to take with CPQ software.